Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Carlson

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Blood|March 25, 2017
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemiaRamiro Garzon, Michael Savona, Rachid Baz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid TumorsAlbiruni R Abdul Razak, Morten Mau-Soerensen, Nashat Y Gabrail, et al.
Nature Biotechnology|February 20, 2018
Random access in large-scale DNA data storageLee Organick, Siena Dumas Ang, Yuan-Jyue Chen, et al.
Nature Biotechnology|July 7, 2018
Erratum: Random access in large-scale DNA data storageLee Organick, Siena Dumas Ang, Yuan-Jyue Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituentUday R Khire, Donald Bankston, James Barbosa, et al.
Infection Control and Hospital Epidemiology|March 20, 2018
Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort StudyMini Kamboj, Teresa Childers, Jessica Sugalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue SarcomaMrinal M Gounder, Alona Zer, William D Tap, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Blood|March 25, 2017
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemiaRamiro Garzon, Michael Savona, Rachid Baz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid TumorsAlbiruni R Abdul Razak, Morten Mau-Soerensen, Nashat Y Gabrail, et al.
Nature Biotechnology|February 20, 2018
Random access in large-scale DNA data storageLee Organick, Siena Dumas Ang, Yuan-Jyue Chen, et al.
Nature Biotechnology|July 7, 2018
Erratum: Random access in large-scale DNA data storageLee Organick, Siena Dumas Ang, Yuan-Jyue Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituentUday R Khire, Donald Bankston, James Barbosa, et al.
Infection Control and Hospital Epidemiology|March 20, 2018
Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort StudyMini Kamboj, Teresa Childers, Jessica Sugalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue SarcomaMrinal M Gounder, Alona Zer, William D Tap, et al.
Pageof 5